- Home
- ABUS vs ITRN Comparison
ABUS vs ITRN Comparison
Compare ABUS & ITRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- ITRN
- Stock Information
- Founded
- ABUS 2005
- ITRN 1994
- Country
- ABUS United States
- ITRN Israel
- Employees
- ABUS N/A
- ITRN N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- ITRN Electronic Components
- Sector
- ABUS Health Care
- ITRN Technology
- Exchange
- ABUS Nasdaq
- ITRN Nasdaq
- Market Cap
- ABUS 711.2M
- ITRN 810.3M
- IPO Year
- ABUS N/A
- ITRN 2005
- Fundamental
- Price
- ABUS $4.38
- ITRN $35.91
- Analyst Decision
- ABUS Strong Buy
- ITRN Buy
- Analyst Count
- ABUS 2
- ITRN 1
- Target Price
- ABUS $5.00
- ITRN $50.00
- AVG Volume (30 Days)
- ABUS 1.4M
- ITRN 94.0K
- Earning Date
- ABUS 11-05-2025
- ITRN 11-20-2025
- Dividend Yield
- ABUS N/A
- ITRN 5.57%
- EPS Growth
- ABUS N/A
- ITRN 9.57
- EPS
- ABUS N/A
- ITRN 2.79
- Revenue
- ABUS $15,416,000.00
- ITRN $339,610,000.00
- Revenue This Year
- ABUS $138.02
- ITRN $7.03
- Revenue Next Year
- ABUS N/A
- ITRN $9.69
- P/E Ratio
- ABUS N/A
- ITRN $12.86
- Revenue Growth
- ABUS 53.23
- ITRN 3.30
- 52 Week Low
- ABUS $2.71
- ITRN $25.87
- 52 Week High
- ABUS $5.10
- ITRN $45.43
- Technical
- Relative Strength Index (RSI)
- ABUS 54.52
- ITRN 51.24
- Support Level
- ABUS $4.25
- ITRN $35.07
- Resistance Level
- ABUS $4.66
- ITRN $35.80
- Average True Range (ATR)
- ABUS 0.17
- ITRN 0.71
- MACD
- ABUS -0.03
- ITRN 0.20
- Stochastic Oscillator
- ABUS 41.67
- ITRN 80.08
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About ITRN Ituran Location and Control Ltd.
Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.